1[1]Kamath S,Blann AD,Lip GY.Platelets and atrial fibrillation.Eur Heart J.2001,22:2233-2242.
2[3]Al-Saady NM,Obel OA,Camm AJ.Left atrial appendage:structure,function,and role in thromboembolism.Heart,1999,82:547-554.
3[4]Salam AM,Al-Mousa EN.The therapeutic potential of ximelagatran to become the anticoagulant of choice in medicine:a review of recently completed clinical trials.Expert Opin Pharmacother,2004,5:1423-1430.
4[5]Kamath S,Blann AD,Lip GY.Platelets and atrial fibrillation.Eur Heart J,2001,22:2233-2242.
5[6]Boyaci A,Topaloglu S,Yilmaz S.Regional left atrial coagulation and fibrinolytic activities in patients with mitral stenosis.Jpn Heart J,2004,45:779-788.
6[7]Little SH,Massel DR.Antiplatelet and anticoagulation for patients with prosthetic heart valves.Cochrane Database Syst Rev,2003,(4):CD003464.